Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques

Carlo Condello1, Peng Yuan2, Aaron Schain1

  • 1Department of Neurology, Yale University, New Haven, Connecticut 06511, USA.

Nature Communications
|January 30, 2015
PubMed

Insights

Microglia form a barrier around Alzheimer's disease plaques, impacting their composition and toxicity. This barrier

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Alzheimer's disease (AD) is characterized by β-amyloid (Aβ) plaques.
  • Microglia processes tightly envelop Aβ plaques, but their role is unclear.

Purpose of the Study:

  • To investigate the significance of microglia enveloping Aβ plaques in Alzheimer's disease.
  • To understand the impact of microglia barriers on plaque composition and neurotoxicity.

Main Methods:

  • High-resolution confocal microscopy.
  • In vivo two-photon imaging in AD mouse models.
  • Analysis of plaque composition, compactness, and association with neuritic dystrophy.

Main Results:

  • Microglia form a barrier that limits plaque expansion and creates compact regions with low Aβ42 affinity.
  • Uncovered areas form protofibrillar Aβ42 hotspots, correlating with severe axonal dystrophy.
  • Reduced microglia coverage in aging exacerbates these hotspots and dystrophy.
  • CX3CR1 deletion or anti-Aβ immunotherapy increases microglia coverage and reduces dystrophy.

Conclusions:

  • The microglia barrier critically influences Alzheimer's disease plaque pathology.
  • Failure of this barrier and accumulation of neurotoxic Aβ hotspots are key drivers of neurodegeneration.
  • Targeting the microglia barrier and Aβ hotspots may offer novel therapeutic and diagnostic strategies for AD.